Equity Overview
Price & Market Data
Price: $1.42
Daily Change: +$0.0681 / 4.80%
Range: $1.38 - $1.42
Market Cap: $51,380,000
Volume: 4,528
Performance Metrics
1 Week: 15.45%
1 Month: -13.99%
3 Months: -33.95%
6 Months: -40.83%
1 Year: -43.43%
YTD: -23.24%
Company Details
Employees: 60
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.